Albany Molecular Research Inc (NASDAQ:AMRI)

17.56
Delayed Data
As of Mar 27
 +0.14 / +0.80%
Today’s Change
13.73
Today|||52-Week Range
23.95
+7.86%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.50, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +16.74% increase from the last price of 17.56.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.15
Sales
$81.5M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -46.40%
 
 
 
 
 
 
Growthannually 30.28%
 
 
 
 
 
 

Sales

Growthquarterly -5.89%
 
 
 
 
 
 
Growthannually 30.75%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account